Kashish Goel
YOU?
Author Swipe
View article: Outcomes of Tricuspid Transcatheter Edge-to-Edge Valve Repair in End-Stage Renal Disease
Outcomes of Tricuspid Transcatheter Edge-to-Edge Valve Repair in End-Stage Renal Disease Open
View article: 71604 | Trisol Valve Treating Patients With Severe RV Disfunction
71604 | Trisol Valve Treating Patients With Severe RV Disfunction Open
View article: 71788 | Association of Site Volume and MitraClip Outcomes in Secondary Mitral Regurgitation: Insights From the COAPT PAS Registry
71788 | Association of Site Volume and MitraClip Outcomes in Secondary Mitral Regurgitation: Insights From the COAPT PAS Registry Open
View article: Tricuspid Regurgitation and 3-Year Mortality After Transseptal Mitral Valve-in-Valve Replacement
Tricuspid Regurgitation and 3-Year Mortality After Transseptal Mitral Valve-in-Valve Replacement Open
Preprocedural severe or greater TR, 30-day residual severe or greater TR, and unchanged or worsened TR after transseptal MViV were associated with a significantly increased risk for 3-year all-cause mortality. These findings underscore the…
View article: Variability in State-Level Regulations Regarding Occupational Radiation Exposure
Variability in State-Level Regulations Regarding Occupational Radiation Exposure Open
View article: Cardiac Biomarkers in Patients With Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial
Cardiac Biomarkers in Patients With Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial Open
BACKGROUND: The EARLY TAVR trial (Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis) demonstrated that early transcatheter aortic valve replacement (TAVR) intervention was superior to clinica…
View article: Lithotripsy-Facilitated or Conventional Percutaneous Mitral Balloon Valvuloplasty for Calcific Mitral Valve Disease: A Systematic Review
Lithotripsy-Facilitated or Conventional Percutaneous Mitral Balloon Valvuloplasty for Calcific Mitral Valve Disease: A Systematic Review Open
View article: Contemporary Outcomes and Trends for the Transseptal Mitral Valve-in-Valve Procedure Using Balloon Expandable Transcatheter Valves in the United States
Contemporary Outcomes and Trends for the Transseptal Mitral Valve-in-Valve Procedure Using Balloon Expandable Transcatheter Valves in the United States Open
BACKGROUND: Previous transcatheter valve therapy registry analyses of transcatheter mitral valve in valve (MViV) replacement of degenerated bioprosthesis reported early experience in the United States. Given recent increases in transseptal…
View article: DOES BASELINE SUB-FOVEAL CHORIODAL THICKNESS DETERMINES TREATMENT RESPONSE TO INTRAVITREAL AFLIBERCEPT IN DIABETIC MACULAR EDEMA?
DOES BASELINE SUB-FOVEAL CHORIODAL THICKNESS DETERMINES TREATMENT RESPONSE TO INTRAVITREAL AFLIBERCEPT IN DIABETIC MACULAR EDEMA? Open
Introduction: To determine the predictive value of baseline SFCT for response to treatment with serial intravitreal aflibercept injections for diabetic macular edema (DME). Methods: A prospective multi-center study was done. Eyes with DME …
View article: Backed Against a Wall: Iatrogenic Type A Aortic Dissection Pinned by Transcatheter Aortic Valve
Backed Against a Wall: Iatrogenic Type A Aortic Dissection Pinned by Transcatheter Aortic Valve Open
View article: Mitral Interventions in Heart Failure
Mitral Interventions in Heart Failure Open
View article: Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock
Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock Open
Aims The safety and efficacy of transcatheter aortic valve replacement (TAVR) with contemporary balloon expandable transcatheter valves in patients with cardiogenic shock (CS) remain largely unknown. In this study, the TAVRs performed for …
View article: Ventricular Remodeling and Outcomes After Mitral Transcatheter Edge-to-Edge Repair in Heart Failure
Ventricular Remodeling and Outcomes After Mitral Transcatheter Edge-to-Edge Repair in Heart Failure Open
View article: D-33 | Transcatheter Edge-to-Edge Repair for Patients With Hypertrophic Cardiomyopathy and Severe Mitral Regurgitation Following Septal Myectomy
D-33 | Transcatheter Edge-to-Edge Repair for Patients With Hypertrophic Cardiomyopathy and Severe Mitral Regurgitation Following Septal Myectomy Open
Concomitant mitral valve surgery during septal myectomy for hypertrophic cardiomyopathy (HCM) is performed in <10% of patients and is associated with increased mortality. The objective of this study is to evaluate the feasibility, safety, …
View article: 3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis
3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis Open
Within the Evolut Low Risk study, TAVR at 3 years showed durable benefits compared with surgery with respect to all-cause mortality or disabling stroke. (Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients; NCT0270…
View article: Impact of Transcatheter Mitral Valve Repair Availability on Volume and Outcomes of Surgical Repair
Impact of Transcatheter Mitral Valve Repair Availability on Volume and Outcomes of Surgical Repair Open
View article: Transcatheter Tricuspid Interventions: Past, Present, and Future
Transcatheter Tricuspid Interventions: Past, Present, and Future Open
Tricuspid regurgitation (TR) etiologies include primary valve pathology or secondary (functional) regurgitation from increased hemodynamic pressure or volume on the right side of the heart. Patients with severe TR have a worse prognosis in…
View article: Association of Transcatheter Aortic Valve Replacement Reimbursement, New Technology Add-on Payment, and Procedure Volumes With Embolic Protection Device Use
Association of Transcatheter Aortic Valve Replacement Reimbursement, New Technology Add-on Payment, and Procedure Volumes With Embolic Protection Device Use Open
EPD use during TAVR remains infrequent and is associated with multiple patient and site characteristics. While CMS reimbursement varies significantly across institutions, TAVR case volume, rather than CMS TAVR reimbursement or the CMS new …
View article: Corrigendum to “Successful Orbital Atherectomy of Left Main Bifurcation Lesion Using Microcatheter Protection of Nonatherectomy Wire”
Corrigendum to “Successful Orbital Atherectomy of Left Main Bifurcation Lesion Using Microcatheter Protection of Nonatherectomy Wire” Open
View article: Successful Orbital Atherectomy of Left Main Bifurcation Lesion Using Microcatheter Protection of Nonatherectomy Wire
Successful Orbital Atherectomy of Left Main Bifurcation Lesion Using Microcatheter Protection of Nonatherectomy Wire Open
-Optimal PCI may be challenging with calcified left main bifurcation lesions-Orbital atherectomy is a common strategy for lesion optimization-Side branch occlusion is a feared complication of orbital atherectomy-Utilizing microcatheter wir…
View article: Surgical Explantation After TAVR Failure
Surgical Explantation After TAVR Failure Open
View article: Impact of Musculoskeletal Limitations on Cardiac Rehabilitation Participation
Impact of Musculoskeletal Limitations on Cardiac Rehabilitation Participation Open
Background: To help clarify a potential barrier to cardiac rehabilitation (CR) participation we sought to examine the association between musculoskeletal limitations (MSLs) and CR enrollment and participation. Methods: Consecutive CR eligi…
View article: Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement
Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement Open
Background Gait speed is a reliable measure of physical function and frailty in patients with aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Slow gait speed pre‐TAVR predicts worse clinical outcomes post‐TAVR. Th…
View article: Association of Natriuretic Peptide Levels After Transcatheter Aortic Valve Replacement With Subsequent Clinical Outcomes
Association of Natriuretic Peptide Levels After Transcatheter Aortic Valve Replacement With Subsequent Clinical Outcomes Open
Elevated BNP levels after TAVR was independently associated with increased subsequent mortality and rehospitalizations. Further studies to determine how best to mitigate this risk are warranted.
View article: Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics
Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics Open
View article: Contemporary Management of Secondary Mitral Regurgitation
Contemporary Management of Secondary Mitral Regurgitation Open
Secondary mitral regurgitation (SMR) is a common occurrence in patients with heart failure with reduced ejection fraction. Moderate-severe or severe SMR is associated with increased mortality and hospitalisations from heart failure. Medica…
View article: Technical Considerations and Pitfalls of BASILICA: Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction
Technical Considerations and Pitfalls of BASILICA: Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction Open
Coronary obstruction is a major complication of transcatheter aortic valve replacement (TAVR). Rapid and growing demand for TAVR procedures is accompanied by interest in techniques that may prevent this life-threatening adverse event. BASI…
View article: Hypoattenuated Leaflet Thickening After Transcatheter Aortic Valve Replacement
Hypoattenuated Leaflet Thickening After Transcatheter Aortic Valve Replacement Open
View article: Lower Blood Pressure After Transcatheter or Surgical Aortic Valve Replacement is Associated with Increased Mortality
Lower Blood Pressure After Transcatheter or Surgical Aortic Valve Replacement is Associated with Increased Mortality Open
Background Blood pressure ( BP ) guidelines for patients with aortic stenosis or a history of aortic stenosis treated with aortic valve replacement ( AVR ) match those in the general population, but this extrapolation may not be warranted.…
View article: Relationship between procedural characteristics and cerebrovascular events after transcatheter aortic valve replacement
Relationship between procedural characteristics and cerebrovascular events after transcatheter aortic valve replacement Open
Objectives The objective was to assess the impact of procedural characteristics on risk of stroke or transient ischaemic attack (TIA) after transcatheter aortic valve replacement (TAVR). Methods We included 370 consecutive patients who und…